Robert Bradway vs Richard Paulson

Robert Bradway

CEO of Amgen

BIO: Mr. Robert A. Bradway, also known as Bob, has been the Chief Executive Officer of Amgen Inc. since May 23, 2012. Mr. Bradway is responsible for the Amgen's global commercial operations, manufacturing operations, information technology, global government affairs and worldwide compliance and business ethics organizations. He served as the President of Amgen Inc. from May 2010 to May 2012. He served as the Chief Operating Officer of Amgen from May 2010 to May 23, 2012. He served as the Chief Financial Officer and Executive Vice President at Amgen Inc. from April 10, 2007 to May 2010. Mr. Bradway joined Amgen in 2006 and served as its Vice President of Operations Strategy. He served as Managing Director in investment banking at Morgan Stanley, where he was responsible for the Morgan Stanley's banking department and corporate finance activities in Europe. He joined Morgan Stanley in New York as a health care industry investment banker in 1985 and moved to London in 1990, where he served as the Head of the Morgan Stanley's international health care investment banking activities. He has been the Chairman of Amgen Inc. since January 1, 2013. He has been an Independent Director of The Boeing Company since October 14, 2016. He has been a Director at Amgen Inc. since October 2011. He serves as a Trustee of University of Southern California. He served as an Independent Director of Norfolk Southern Corporation from July 2011 to May 11, 2017. He served as a Director of Micromet, Inc. from March 2, 2012 to March 7, 2012. He is chairman of the CEO Roundtable on Cancer, a non-profit organization comprised of executives founded to have solutions to cancer treatment and prevention. He holds a B.A in Biology from Amherst College and an MBA from Harvard University.

Richard Paulson

CEO of Karyopharm Therapeutics

BIO: Mr. Paulson was appointed President and Chief Executive Officer of Karyopharm in May 2021 and has served as a member of Karyopharm’s Board of Directors since February 2020. He was previously an Executive Vice President of Ipsen Pharmaceuticals, Inc. and Chief Executive Officer of Ipsen North America, a global biopharmaceutical company focused on innovation and specialty care in areas of oncology, neuroscience and rare diseases, from February 2018 to May 2021. Mr. Paulson previously worked at Amgen for 10 years holding varying leadership positions across Europe and North America, including Vice President and General Manager of Amgen’s U.S. Oncology Business Unit, and prior to that served as the Vice President of Marketing for Amgen’s U.S. Oncology Business, General Manager of Amgen Germany, and General Manager of Amgen Central & Eastern Europe. Prior to Amgen, Mr. Paulson held a number of global leadership positions at Pfizer Inc., including serving as General Manager of Pfizer South Africa and Pfizer Czech Republic. Mr. Paulson also previously held a variety of sales, marketing, and market access roles with increasing seniority at GlaxoWellcome in Canada. Mr. Paulson has an MBA from the University of Toronto, Canada and an undergraduate degree in commerce from the University of Saskatchewan, Canada.